Logo image
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations
Journal article   Open access   Peer reviewed

Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations

Kristin A Shimano, Ghadir Sasa, Larisa Broglie, Nicholas J Gloude, Kasiani Myers, Taizo A Nakano, Anjali Sharathkumar, Jennifer A Rothman, Maria A Pereda, Kathleen Overholt, …
Pediatric blood & cancer, Vol.71(8), e31075
08/2024
DOI: 10.1002/pbc.31075
PMID: 38764170
url
https://doi.org/10.1002/pbc.31075View
Published (Version of record) Open Access

Abstract

Severe aplastic anemia (SAA) is a rare potentially fatal hematologic disorder. Although overall outcomes with treatment are excellent, there are variations in management approach, including differences in treatment between adult and pediatric patients. Certain aspects of treatment are under active investigation in clinical trials. Because of the rarity of the disease, some pediatric hematologists may have relatively limited experience with the complex management of SAA. The following recommendations reflect an up-to-date evidence-based approach to the treatment of children with relapsed or refractory SAA.
bone marrow failure aplastic anemia pediatric hematology/oncology

Details

Metrics

Logo image